表紙:ドライアイ症候群の世界市場調査レポート:2021年
市場調査レポート
商品コード
998901

ドライアイ症候群の世界市場調査レポート:2021年

Global Dry Eye Syndrome Market Research Report 2021

出版日: | 発行: QYResearch | ページ情報: 英文 116 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.10円
ドライアイ症候群の世界市場調査レポート:2021年
出版日: 2021年04月08日
発行: QYResearch
ページ情報: 英文 116 Pages
納期: 2-3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界におけるドライアイ症候群の市場規模は、2020年に51億3,400万米ドルと評価され、2027年末までに69億9,300万米ドルに達し、2021年から2027年の間に4.45%のCAGRで成長すると予測されています。

当レポートでは、世界のドライアイ症候群市場について調査し、主要企業、各セグメントおよび地域別による市場規模の予測、主要企業のプロファイル、競合情勢と影響要因の分析などを提供しています。

目次

第1章 ドライアイ症候群:市場概要

  • ドライアイ症候群:製品概要・範囲
  • セグメント:タイプ別
    • 世界のドライアイ症候群の市場の成長率の比較:タイプ別
    • 人工涙液
    • 抗炎症薬
  • セグメント:アプリケーション別
    • 世界の売上高の比較:アプリケーション別
    • 病院
    • 小売薬局
  • 世界のドライアイ症候群市場規模の推計・予測
    • 世界のドライアイ症候群の収益
    • 世界のドライアイ症候群の売上高
    • ドライアイ症候群の市場規模:地域別

第2章 市場競合:メーカー別

  • 世界市場の売上シェア:メーカー別
  • 世界市場の収益シェア:メーカー別
  • 世界の平均価格:メーカー別
  • メーカーの生産拠点、提供地域、製品タイプ
  • 市場の競争状況と動向
    • 市場集中率
    • 世界の上位5社の市場シェア:収益別
    • 企業タイプ別の市場シェア(Tier 1、Tier 2、Tier 3)
  • メーカーの合併と買収、拡張計画

第3章 ドライアイ症候群のレトロスペクティブ市場シナリオ:地域別

  • 売上高における世界のドライアイ症候群のレトロスペクティブ市場シナリオ:地域別
  • 収益における世界のドライアイ症候群のレトロスペクティブ市場シナリオ:地域別
  • 北米のドライアイ症候群市場のデータ:国別
    • 売上高:国別
    • 収益:国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州のドライアイ症候群市場のデータ:国別
    • 売上高:国別
    • 収益:国別
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • ロシア
  • アジア太平洋のドライアイ症候群市場のデータ:国別
    • 売上高:地域別
    • 収益:地域別
    • 中国
    • 日本
    • 韓国
    • インド
    • 東南アジア
  • 南米のドライアイ症候群市場のデータ:国別
    • 売上高:国別
    • 収益:国別
    • ブラジル
  • 中東・アフリカのドライアイ症候群市場のデータ:国別
    • 売上高:国別
    • 収益:国別
    • トルコ
    • サウジアラビア
    • アラブ首長国連邦

第4章 ドライアイ症候群の市場規模実績:タイプ別

  • 世界のドライアイ症候群の売上市場シェア:タイプ別
  • 世界のドライアイ症候群の収益市場シェア:タイプ別
  • 世界のドライアイ症候群の価格:タイプ別

第5章 ドライアイ症候群の市場規模実績:アプリケーション別

  • 世界のドライアイ症候群の売上市場シェア:アプリケーション別
  • 世界のドライアイ症候群の収益市場シェア:アプリケーション別
  • 世界のドライアイ症候群の価格:アプリケーション別

第6章 主要企業の概要

  • Allergan
  • Alcon
  • Novartis
  • Santen Pharmaceutical
  • Johnson & Johnson
  • Bausch & Lomb
  • Thea Pharmaceuticals
  • URSAPHARM
  • SIMILASAN
  • Akorn
  • United Laboratories
  • Sun Pharmaceutical
  • Jianfeng Group

第7章 製造コスト分析

  • 主要原材料分析
    • 主要原材料
    • 原材料の主要サプライヤー
  • 製造コスト構造比
  • 製造プロセス分析
  • 産業チェーン分析

第8章 マーケティングチャネル、ディストリビューター、および顧客

  • マーケティングチャネル
  • ディストリビューターリスト
  • 顧客

第9章 市場力学

  • 業界の動向
  • 成長要因
  • 市場の課題
  • ポーターのファイブフォース分析

第10章 世界市場の予測

  • 市場推計・予測:タイプ別
    • 世界の売上予測:タイプ別
    • 世界の収益予測:タイプ別
  • 市場推計・予測:アプリケーション別
    • 世界の売上予測:アプリケーション別
    • 世界の収益予測:アプリケーション別
  • 市場推計・予測:地域別
    • 世界の売上予測:地域別
    • 世界の収益予測:地域別

第11章 調査結果・結論

第12章 調査手法とデータソース

  • 調査手法/調査アプローチ
    • 調査プログラム/デザイン
    • 市場規模の見積もり
    • 市場の内訳とデータの三角測量
  • 情報ソース
    • 二次資料
    • 一次情報源
  • 著者リスト
  • 免責事項
図表

List of Tables and Figures

  • Table 1. Global Dry Eye Syndrome Sales (M Unit) and Revenue (M USD) Growth Rate Comparison by Type (2021-2027)
  • Table 2. Global Dry Eye Syndrome Sales (M Unit) Comparison by Application (2021-2027)
  • Table 3. Global Dry Eye Syndrome Market Size by Region (US$ Million): 2016 VS 2021 VS 2027
  • Table 4. Key Manufacturers Dry Eye Syndrome Covered in This Study
  • Table 5. Global Dry Eye Syndrome Sales (M Unit) of Key Manufacturers (2019-2021)
  • Table 6. Global Dry Eye Syndrome Sales Market Share by Manufacturers (2019-2021)
  • Table 7. Global Dry Eye Syndrome Revenue (US$ Million) by Manufacturers (2019-2021)
  • Table 8. Global Dry Eye Syndrome Revenue Share by Manufacturers (2019-2021)
  • Table 9. Global Market Dry Eye Syndrome Average Price (USD/Unit) of Key Manufacturers (2019-2021)
  • Table 10. Manufacturers Dry Eye Syndrome Manufacturing Sites and Area Served
  • Table 11. Manufacturers Dry Eye Syndrome Product Type
  • Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 13. Global Dry Eye Syndrome by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Eye Syndrome as of 2020)
  • Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
  • Table 15. Global Dry Eye Syndrome Sales by Region (2016-2021) & (M Unit)
  • Table 16. Global Dry Eye Syndrome Sales Market Share by Region (2016-2021)
  • Table 17. Global Dry Eye Syndrome Revenue by Region (2016-2021) & (US$ Million)
  • Table 18. Global Dry Eye Syndrome Revenue Market Share by Region (2016-2021)
  • Table 19. North America Dry Eye Syndrome Sales by Country (2016-2021) & (M Unit)
  • Table 20. North America Dry Eye Syndrome Sales Market Share by Country (2016-2021)
  • Table 21. North America Dry Eye Syndrome Revenue by Country (2016-2021) & (US$ Million)
  • Table 22. North America Dry Eye Syndrome Revenue Market Share by Country (2016-2021)
  • Table 23. Europe Dry Eye Syndrome Sales by Country (2016-2021) & (M Unit)
  • Table 24. Europe Dry Eye Syndrome Sales Market Share by Country (2016-2021)
  • Table 25. Europe Dry Eye Syndrome Revenue by Country (2016-2021) & (US$ Million)
  • Table 26. Europe Dry Eye Syndrome Revenue Market Share by Country (2016-2021)
  • Table 27. Asia Pacific Dry Eye Syndrome Sales by Region (2016-2021) & (M Unit)
  • Table 28. Asia Pacific Dry Eye Syndrome Sales Market Share by Region (2016-2021)
  • Table 29. Asia Pacific Dry Eye Syndrome Revenue by Region (2016-2021) & (US$ Million)
  • Table 30. Asia Pacific Dry Eye Syndrome Revenue Market Share by Region (2016-2021)
  • Table 31. South America Dry Eye Syndrome Sales by Country (2016-2021) & (M Unit)
  • Table 32. South America Dry Eye Syndrome Sales Market Share by Country (2016-2021)
  • Table 33. South America Dry Eye Syndrome Revenue by Country (2016-2021) & (US$ Million)
  • Table 34. South America Dry Eye Syndrome Revenue Market Share by Country (2016-2021)
  • Table 35. Middle East and Africa Dry Eye Syndrome Sales by Country (2016-2021) & (M Unit)
  • Table 36. Middle East and Africa Dry Eye Syndrome Sales Market Share by Country (2016-2021)
  • Table 37. Middle East and Africa Dry Eye Syndrome Revenue by Country (2016-2021) & (US$ Million)
  • Table 38. Middle East and Africa Dry Eye Syndrome Revenue Market Share by Country (2016-2021)
  • Table 39. Global Dry Eye Syndrome Sales (M Unit) by Type (2016-2021)
  • Table 40. Global Dry Eye Syndrome Sales Market Share by Type (2016-2021)
  • Table 41. Global Dry Eye Syndrome Revenue (US$ Million) by Type (2016-2021)
  • Table 42. Global Dry Eye Syndrome Revenue Share by Type (2016-2021)
  • Table 43. Global Dry Eye Syndrome Price (USD/Unit) by Type (2016-2021)
  • Table 44. Global Dry Eye Syndrome Sales (M Unit) by Application (2016-2021)
  • Table 45. Global Dry Eye Syndrome Sales Market Share by Application (2016-2021)
  • Table 46. Global Dry Eye Syndrome Revenue (US$ Million) by Application (2016-2021)
  • Table 47. Global Dry Eye Syndrome Revenue Share by Application (2016-2021)
  • Table 48. Global Dry Eye Syndrome Price (USD/Unit) by Application (2016-2021)
  • Table 49. Allergan Corporation Information
  • Table 50. Allergan Description and Business Overview
  • Table 51. Allergan Dry Eye Syndrome Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 52. Allergan Dry Eye Syndrome Product
  • Table 53. Allergan Recent Developments/Updates
  • Table 54. Alcon Corporation Information
  • Table 55. Alcon Description and Business Overview
  • Table 56. Alcon Dry Eye Syndrome Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 57. Alcon Dry Eye Syndrome Product
  • Table 58. Alcon Recent Developments/Updates
  • Table 59. Novartis Corporation Information
  • Table 60. Novartis Description and Business Overview
  • Table 61. Novartis Dry Eye Syndrome Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 62. Novartis Dry Eye Syndrome Product
  • Table 63. Novartis Recent Developments/Updates
  • Table 64. Santen Pharmaceutical Corporation Information
  • Table 65. Santen Pharmaceutical Description and Business Overview
  • Table 66. Santen Pharmaceutical Dry Eye Syndrome Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 67. Santen Pharmaceutical Dry Eye Syndrome Product
  • Table 68. Johnson & Johnson Corporation Information
  • Table 69. Johnson & Johnson Description and Business Overview
  • Table 70. Johnson & Johnson Dry Eye Syndrome Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 71. Johnson & Johnson Dry Eye Syndrome Product
  • Table 72. Johnson & Johnson Recent Developments/Updates
  • Table 73. Bausch & Lomb Corporation Information
  • Table 74. Bausch & Lomb Description and Business Overview
  • Table 75. Bausch & Lomb Dry Eye Syndrome Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 76. Bausch & Lomb Dry Eye Syndrome Product
  • Table 77. Thea pharmaceuticals Corporation Information
  • Table 78. Thea pharmaceuticals Description and Business Overview
  • Table 79. Thea pharmaceuticals Dry Eye Syndrome Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 80. Thea pharmaceuticals Dry Eye Syndrome Product
  • Table 81. URSAPHARM Corporation Information
  • Table 82. URSAPHARM Description and Business Overview
  • Table 83. URSAPHARM Dry Eye Syndrome Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 84. SIMILASAN Corporation Information
  • Table 85. SIMILASAN Description and Business Overview
  • Table 86. SIMILASAN Dry Eye Syndrome Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 87. SIMILASAN Dry Eye Syndrome Product
  • Table 88. Akorn Corporation Information
  • Table 89. Akorn Description and Business Overview
  • Table 90. Akorn Dry Eye Syndrome Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 91. United Laboratories Corporation Information
  • Table 92. United Laboratories Description and Business Overview
  • Table 93. United Laboratories Dry Eye Syndrome Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 94. Sun Pharmaceutical Corporation Information
  • Table 95. Sun Pharmaceutical Description and Business Overview
  • Table 96. Sun Pharmaceutical Dry Eye Syndrome Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 97. Sun Pharmaceutical Dry Eye Syndrome Product
  • Table 98. Sun Pharmaceutical Recent Developments/Updates
  • Table 99. Jianfeng Group Corporation Information
  • Table 100. Jianfeng Group Description and Business Overview
  • Table 101. Jianfeng Group Dry Eye Syndrome Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2021)
  • Table 102. Production Base and Market Concentration Rate of Raw Material
  • Table 103. Key Suppliers of Raw Materials
  • Table 104. Dry Eye Syndrome Distributors List
  • Table 105. Dry Eye Syndrome Customers List
  • Table 106. Dry Eye Syndrome Market Trends
  • Table 107. Dry Eye Syndrome Growth Drivers
  • Table 108. Dry Eye Syndrome Market Challenges
  • Table 109. Global Dry Eye Syndrome Sales Forecast by Type (2022-2027) & (M Unit)
  • Table 110. Global Dry Eye Syndrome Sales Market Share Forecast by Type (2022-2027)
  • Table 111. Global Dry Eye Syndrome Revenue Forecast by Type (2022-2027) & (US$ Million)
  • Table 112. Global Dry Eye Syndrome Revenue Market Share Forecast by Type (2022-2027)
  • Table 113. Global Dry Eye Syndrome Sales Forecast by Application (2022-2027) & (M Unit)
  • Table 114. Global Dry Eye Syndrome Sales Market Share Forecast by Application (2022-2027)
  • Table 115. Global Dry Eye Syndrome Revenue Forecast by Application (2022-2027) & (US$ Million)
  • Table 116. Global Dry Eye Syndrome Revenue Market Share Forecast by Application (2022-2027)
  • Table 117. Global Dry Eye Syndrome Sales Forecast by Region (2022-2027) & (M Unit)
  • Table 118. Global Dry Eye Syndrome Sales Market Share Forecast by Region (2022-2027)
  • Table 119. Global Dry Eye Syndrome Revenue Forecast by Region (2022-2027) & (US$ Million)
  • Table 120. Global Dry Eye Syndrome Revenue Market Share Forecast by Region (2022-2027)
  • Table 121. Research Programs/Design for This Report
  • Table 122. Key Data Information from Secondary Sources
  • Table 123. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Product Picture of Dry Eye Syndrome
  • Figure 2. Global Dry Eye Syndrome Market Share by Type in 2020
  • Figure 3. Global Dry Eye Syndrome Market Share by Type in 2027
  • Figure 4. Artificial Tears Product Picture
  • Figure 5. Anti-inflammatory Drugs Product Picture
  • Figure 6. Global Dry Eye Syndrome Market Share by Application in 2020
  • Figure 7. Global Dry Eye Syndrome Market Share by Application in 2027
  • Figure 8. Hospital
  • Figure 9. Retail Pharmacy
  • Figure 10. Global Dry Eye Syndrome Revenue, (US$ Million), 2016 VS 2021 VS 2027
  • Figure 11. Global Dry Eye Syndrome Market Size 2016-2027 (US$ Million)
  • Figure 12. Global Dry Eye Syndrome Sales 2016-2027 (M Unit)
  • Figure 13. Global Dry Eye Syndrome Market Size by Region: 2016 VS 20210 VS 2027
  • Figure 14. Dry Eye Syndrome Sales Share by Manufacturers in 2020
  • Figure 15. Global Dry Eye Syndrome Revenue Share by Manufacturers in 2020
  • Figure 16. Global 5 Largest Dry Eye Syndrome Players: Market Share by Revenue in Dry Eye Syndrome in 2020
  • Figure 17. Global Dry Eye Syndrome Sales Market Share by Region (2016-2021)
  • Figure 18. Global Dry Eye Syndrome Sales Market Share by Region in 2020
  • Figure 19. Global Dry Eye Syndrome Revenue Market Share by Region in 2020
  • Figure 20. North America Dry Eye Syndrome Sales Market Share by Country in 2020
  • Figure 21. United States Dry Eye Syndrome Revenue Growth Rate (2016-2021) & (US$ Million)
  • Figure 22. Canada Dry Eye Syndrome Revenue Growth Rate (2016-2021) & (US$ Million)
  • Figure 23. Mexico Dry Eye Syndrome Revenue Growth Rate (2016-2021) & (US$ Million)
  • Figure 24. Germany Dry Eye Syndrome Revenue Growth Rate (2016-2021) & (US$ Million)
  • Figure 25. U.K. Dry Eye Syndrome Revenue Growth Rate (2016-2021) & (US$ Million)
  • Figure 26. France Dry Eye Syndrome Revenue Growth Rate (2016-2021) & (US$ Million)
  • Figure 27. Italy Dry Eye Syndrome Revenue Growth Rate (2016-2021) & (US$ Million)
  • Figure 28. Russia Dry Eye Syndrome Revenue Growth Rate (2016-2021) & (US$ Million)
  • Figure 29. China Dry Eye Syndrome Revenue Growth Rate (2016-2021) & (US$ Million)
  • Figure 30. Japan Dry Eye Syndrome Revenue Growth Rate (2016-2021) & (US$ Million)
  • Figure 31. South Korea Dry Eye Syndrome Revenue Growth Rate (2016-2021) & (US$ Million)
  • Figure 32. India Dry Eye Syndrome Revenue Growth Rate (2016-2021) & (US$ Million)
  • Figure 33. Southeast Asia Dry Eye Syndrome Revenue Growth Rate (2016-2021) & (US$ Million)
  • Figure 34. Brazil Dry Eye Syndrome Revenue Growth Rate (2016-2021) & (US$ Million)
  • Figure 35. Turkey Dry Eye Syndrome Revenue Growth Rate (2016-2021) & (US$ Million)
  • Figure 36. Saudi Arabia Dry Eye Syndrome Revenue Growth Rate (2016-2021) & (US$ Million)
  • Figure 37. U.A.E Dry Eye Syndrome Revenue Growth Rate (2016-2021) & (US$ Million)
  • Figure 38. Sales Market Share of Dry Eye Syndrome by Type (2016-2021)
  • Figure 39. Sales Market Share of Dry Eye Syndrome by Application (2016-2021)
  • Figure 40. Sales Market Share of Dry Eye Syndrome by Application in 2020
  • Figure 41. Revenue Share of Dry Eye Syndrome by Application (2016-2021)
  • Figure 42. Revenue Market Share of Dry Eye Syndrome by Application in 2020
  • Figure 43. Akorn Dry Eye Syndrome Product
  • Figure 44. United Laboratories Dry Eye Syndrome Product
  • Figure 45. Jianfeng Group Dry Eye Syndrome Product
  • Figure 46. Manufacturing Cost Structure of Dry Eye Syndrome
  • Figure 47. Manufacturing Process Analysis of Dry Eye Syndrome
  • Figure 48. Dry Eye Syndrome Industrial Chain Analysis
  • Figure 49. Channels of Distribution
  • Figure 50. Distributors Profiles
  • Figure 51. Porter's Five Forces Analysis
  • Figure 52. Bottom-up and Top-down Approaches for This Report
  • Figure 53. Data Triangulation
  • Figure 54. Key Executives Interviewed 98
目次

The global Dry Eye Syndrome market was valued at US$ 5134 million in 2020 and is expected to reach US$ 6993 million by the end of 2027, growing at a CAGR of 4.45% during 2021-2027.

This report focuses on Dry Eye Syndrome volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Dry Eye Syndrome market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, etc.

Global Dry Eye Syndrome Market: Segment Analysis

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

By Company

  • Allergan
  • Alcon
  • Novartis
  • Santen Pharma
  • Johnson & Johnson
  • Bausch & Lomb
  • Thea pharmaceuticals
  • URSAPHARM
  • SIMILASAN
  • Akorn
  • United Laboratories
  • Sun Pharmaceutical
  • Jianfeng Group

Segment by Type

  • Artificial Tears
  • Anti-inflammatory Drugs
  • Other

Segment by Application

  • Hospital
  • Retail Pharmacy
  • Others

By Region

  • North America
  • United States
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Other Regions
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Russia
  • Rest of Europe
  • South America
  • Brazil
  • Rest of South America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • U.A.E
  • Other Regions

TABLE OF CONTENTS

1 DRY EYE SYNDROME MARKET OVERVIEW

  • 1.1 Product Overview and Scope of Dry Eye Syndrome
  • 1.2 Dry Eye Syndrome Segment by Type
    • 1.2.1 Global Dry Eye Syndrome Market Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Artificial Tears
    • 1.2.3 Anti-inflammatory Drugs
  • 1.3 Dry Eye Syndrome Segment by Application
    • 1.3.1 Global Dry Eye Syndrome Sales Comparison by Application (2021-2027)
    • 1.3.2 Hospital
    • 1.3.3 Retail Pharmacy
  • 1.4 Global Dry Eye Syndrome Market Size Estimates and Forecasts
    • 1.4.1 Global Dry Eye Syndrome Revenue 2016-2027
    • 1.4.2 Global Dry Eye Syndrome Sales 2016-2027
    • 1.4.3 Dry Eye Syndrome Market Size by Region: 2016 Versus 2021 Versus 2027

2 DRY EYE SYNDROME MARKET COMPETITION BY MANUFACTURERS

  • 2.1 Global Dry Eye Syndrome Sales Market Share by Manufacturers (2019-2021)
  • 2.2 Global Dry Eye Syndrome Revenue Market Share by Manufacturers (2019-2021)
  • 2.3 Global Dry Eye Syndrome Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Dry Eye Syndrome Manufacturing Sites, Area Served, Product Type
  • 2.5 Dry Eye Syndrome Market Competitive Situation and Trends
    • 2.5.1 Dry Eye Syndrome Market Concentration Rate
    • 2.5.2 The Global 5 Largest Dry Eye Syndrome Players Market Share by Revenue
    • 2.5.3 Global Dry Eye Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 DRY EYE SYNDROME RETROSPECTIVE MARKET SCENARIO BY REGION

  • 3.1 Global Dry Eye Syndrome Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.2 Global Dry Eye Syndrome Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.3 North America Dry Eye Syndrome Market Facts & Figures by Country
    • 3.3.1 North America Dry Eye Syndrome Sales by Country
    • 3.3.2 North America Dry Eye Syndrome Revenue by Country
    • 3.3.3 United States
    • 3.3.4 Canada
    • 3.3.5 Mexico
  • 3.4 Europe Dry Eye Syndrome Market Facts & Figures by Country
    • 3.4.1 Europe Dry Eye Syndrome Sales by Country
    • 3.4.2 Europe Dry Eye Syndrome Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 U.K.
    • 3.4.5 France
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Dry Eye Syndrome Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Dry Eye Syndrome Sales by Region
    • 3.5.2 Asia Pacific Dry Eye Syndrome Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Southeast Asia
  • 3.6 South America Dry Eye Syndrome Market Facts & Figures by Country
    • 3.6.1 South America Dry Eye Syndrome Sales by Country
    • 3.6.2 South America Dry Eye Syndrome Revenue by Country
    • 3.6.3 Brazil
  • 3.7 Middle East and Africa Dry Eye Syndrome Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Dry Eye Syndrome Sales by Country
    • 3.7.2 Middle East and Africa Dry Eye Syndrome Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 U.A.E

4 DRY EYE SYNDROME HISTORIC MARKET ANALYSIS BY TYPE

  • 4.1 Global Dry Eye Syndrome Sales Market Share by Type (2016-2021)
  • 4.2 Global Dry Eye Syndrome Revenue Market Share by Type (2016-2021)
  • 4.3 Global Dry Eye Syndrome Price by Type (2016-2021)

5 DRY EYE SYNDROME HISTORIC MARKET ANALYSIS BY APPLICATION

  • 5.1 Global Dry Eye Syndrome Sales Market Share by Application (2016-2021)
  • 5.2 Global Dry Eye Syndrome Revenue Market Share by Application (2016-2021)
  • 5.3 Global Dry Eye Syndrome Price by Application (2016-2021)

6 KEY COMPANIES PROFILED

  • 6.1 Allergan
    • 6.1.1 Allergan Corporation Information
    • 6.1.2 Allergan Description and Business Overview
    • 6.1.3 Allergan Dry Eye Syndrome Sales, Revenue and Gross Margin (2019-2021)
    • 6.1.4 Allergan Dry Eye Syndrome Product Portfolio
    • 6.1.5 Allergan Recent Developments/Updates
  • 6.2 Alcon
    • 6.2.1 Alcon Corporation Information
    • 6.2.2 Alcon Description and Business Overview
    • 6.2.3 Alcon Dry Eye Syndrome Sales, Revenue and Gross Margin (2019-2021)
    • 6.2.4 Alcon Dry Eye Syndrome Product Portfolio
    • 6.2.5 Alcon Recent Developments/Updates
  • 6.3 Novartis
    • 6.3.1 Novartis Corporation Information
    • 6.3.2 Novartis Description and Business Overview
    • 6.3.3 Novartis Dry Eye Syndrome Sales, Revenue and Gross Margin (2019-2021)
    • 6.3.4 Novartis Dry Eye Syndrome Product Portfolio
    • 6.3.5 Novartis Recent Developments/Updates
  • 6.4 Santen Pharmaceutical
    • 6.4.1 Santen Pharmaceutical Corporation Information
    • 6.4.2 Santen Pharmaceutical Description and Business Overview
    • 6.4.3 Santen Pharmaceutical Dry Eye Syndrome Sales, Revenue and Gross Margin (2019-2021)
    • 6.4.4 Santen Pharmaceutical Dry Eye Syndrome Product Portfolio
  • 6.5 Johnson & Johnson
    • 6.5.1 Johnson & Johnson Corporation Information
    • 6.5.2 Johnson & Johnson Description and Business Overview
    • 6.5.3 Johnson & Johnson Dry Eye Syndrome Sales, Revenue and Gross Margin (2019-2021)
    • 6.5.4 Johnson & Johnson Dry Eye Syndrome Product Portfolio
    • 6.5.5 Johnson & Johnson Recent Developments/Updates
  • 6.6 Bausch & Lomb
    • 6.6.1 Bausch & Lomb Corporation Information
    • 6.6.2 Bausch & Lomb Description and Business Overview
    • 6.6.3 Bausch & Lomb Dry Eye Syndrome Sales, Revenue and Gross Margin (2019-2021)
    • 6.6.4 Bausch & Lomb Dry Eye Syndrome Product Portfolio
  • 6.7 Thea pharmaceuticals
    • 6.7.1 Thea pharmaceuticals Corporation Information
    • 6.7.2 Thea pharmaceuticals Description and Business Overview
    • 6.7.3 Thea pharmaceuticals Dry Eye Syndrome Sales, Revenue and Gross Margin (2019-2021)
    • 6.7.4 Thea pharmaceuticals Dry Eye Syndrome Product Portfolio
  • 6.8 URSAPHARM
    • 6.8.1 URSAPHARM Corporation Information
    • 6.8.2 URSAPHARM Description and Business Overview
    • 6.8.3 URSAPHARM Dry Eye Syndrome Sales, Revenue and Gross Margin (2019-2021)
  • 6.9 SIMILASAN
    • 6.9.1 SIMILASAN Corporation Information
    • 6.9.2 SIMILASAN Description and Business Overview
    • 6.9.3 SIMILASAN Dry Eye Syndrome Sales, Revenue and Gross Margin (2019-2021)
    • 6.9.4 SIMILASAN Dry Eye Syndrome Product Portfolio
  • 6.10 Akorn
    • 6.10.1 Akorn Corporation Information
    • 6.10.2 Akorn Description and Business Overview
    • 6.10.3 Akorn Dry Eye Syndrome Sales, Revenue and Gross Margin (2019-2021)
    • 6.10.4 Akorn Dry Eye Syndrome Product Portfolio
  • 6.11 United Laboratories
    • 6.11.1 United Laboratories Corporation Information
    • 6.11.2 United Laboratories Description and Business Overview
    • 6.11.3 United Laboratories Dry Eye Syndrome Sales, Revenue and Gross Margin (2019-2021)
    • 6.11.4 United Laboratories Dry Eye Syndrome Product Portfolio
  • 6.12 Sun Pharmaceutical
    • 6.12.1 Sun Pharmaceutical Corporation Information
    • 6.12.2 Sun Pharmaceutical Description and Business Overview
    • 6.12.3 Sun Pharmaceutical Dry Eye Syndrome Sales, Revenue and Gross Margin (2019-2021)
    • 6.12.4 Sun Pharmaceutical Dry Eye Syndrome Product Portfolio
    • 6.12.5 Sun Pharmaceutical Recent Developments/Updates
  • 6.13 Jianfeng Group
    • 6.13.1 Jianfeng Group Corporation Information
    • 6.13.2 Jianfeng Group Description and Business Overview
    • 6.13.3 Jianfeng Group Dry Eye Syndrome Sales, Revenue and Gross Margin (2019-2021)
    • 6.13.4 Jianfeng Group Dry Eye Syndrome Product Portfolio

7 DRY EYE SYNDROME MANUFACTURING COST ANALYSIS

  • 7.1 Dry Eye Syndrome Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Dry Eye Syndrome
  • 7.4 Dry Eye Syndrome Industrial Chain Analysis

8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS

  • 8.1 Marketing Channel
  • 8.2 Dry Eye Syndrome Distributors List
  • 8.3 Dry Eye Syndrome Customers

9 DRY EYE SYNDROME MARKET DYNAMICS

  • 9.1 Dry Eye Syndrome Industry Trends
  • 9.2 Dry Eye Syndrome Growth Drivers
  • 9.3 Dry Eye Syndrome Market Challenges
  • 9.4 Porter's Five Forces Analysis

10 GLOBAL MARKET FORECAST

  • 10.1 Dry Eye Syndrome Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Dry Eye Syndrome by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Dry Eye Syndrome by Type (2022-2027)
  • 10.2 Dry Eye Syndrome Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Dry Eye Syndrome by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Dry Eye Syndrome by Application (2022-2027)
  • 10.3 Dry Eye Syndrome Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Dry Eye Syndrome by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Dry Eye Syndrome by Region (2022-2027)

11 RESEARCH FINDINGS AND CONCLUSION

12 METHODOLOGY AND DATA SOURCE

  • 12.1 Methodology/Research Approach
    • 12.1.1 Research Programs/Design
    • 12.1.2 Market Size Estimation
    • 12.1.3 Market Breakdown and Data Triangulation
  • 12.2 Data Source
    • 12.2.1 Secondary Sources
    • 12.2.2 Primary Sources
  • 12.3 Author List
  • 12.4 Disclaimer